GILEAD SCIENCES, INC. GILD
Nasdaq · XNAS · stock · Biological Products, (No Diagnostic Substances) · website · IPO 1992-01-22
GILEAD SCIENCES, INC. institutional holders (13F)
| Investor | Shares | Value |
|---|---|---|
| BlackRock Finance, Inc. | 120,632,023 | $8.3B |
| DODGE & COX | 24,250,826 | $3.4B |
| CITADEL ADVISORS LLC | 6,063,685 | $845.1M |
| MILLENNIUM MANAGEMENT LLC | 2,380,060 | $331.7M |
| RENAISSANCE TECHNOLOGIES LLC | 2,152,528 | $300.0M |
| AQR CAPITAL MANAGEMENT LLC | 1,164,803 | $162.1M |
| D. E. Shaw & Co., Inc. | 220,919 | $30.8M |
| Bridgewater Associates, LP | 180,737 | $25.2M |
Source: SEC EDGAR filings · CIK 0000882095 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.